203 related articles for article (PubMed ID: 28806749)
1. Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study.
Leo PJ; Madeleine MM; Wang S; Schwartz SM; Newell F; Pettersson-Kymmer U; Hemminki K; Hallmans G; Tiews S; Steinberg W; Rader JS; Castro F; Safaeian M; Franco EL; Coutlée F; Ohlsson C; Cortes A; Marshall M; Mukhopadhyay P; Cremin K; Johnson LG; Trimble CL; Garland S; Tabrizi SN; Wentzensen N; Sitas F; Little J; Cruickshank M; Frazer IH; Hildesheim A; Brown MA
PLoS Genet; 2017 Aug; 13(8):e1006866. PubMed ID: 28806749
[TBL] [Abstract][Full Text] [Related]
2. Pooled analysis of genome-wide association studies of cervical intraepithelial neoplasia 3 (CIN3) identifies a new susceptibility locus.
Chen D; Enroth S; Liu H; Sun Y; Wang H; Yu M; Deng L; Xu S; Gyllensten U
Oncotarget; 2016 Jul; 7(27):42216-42224. PubMed ID: 27285765
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide association study of susceptibility loci for cervical cancer.
Chen D; Juko-Pecirep I; Hammer J; Ivansson E; Enroth S; Gustavsson I; Feuk L; Magnusson PK; McKay JD; Wilander E; Gyllensten U
J Natl Cancer Inst; 2013 May; 105(9):624-33. PubMed ID: 23482656
[TBL] [Abstract][Full Text] [Related]
4. A variant upstream of HLA-DRB1 and multiple variants in MICA influence susceptibility to cervical cancer in a Swedish population.
Chen D; Hammer J; Lindquist D; Idahl A; Gyllensten U
Cancer Med; 2014 Feb; 3(1):190-8. PubMed ID: 24403192
[TBL] [Abstract][Full Text] [Related]
5. Genome, HLA and polygenic risk score analyses for prevalent and persistent cervical human papillomavirus (HPV) infections.
Adebamowo SN; Adeyemo A; Adebayo A; Achara P; Alabi B; Bakare RA; Famooto AO; Obende K; Offiong R; Olaniyan O; Ologun S; Rotimi C; ; Adebamowo CA
Eur J Hum Genet; 2024 Jun; 32(6):708-716. PubMed ID: 38200081
[TBL] [Abstract][Full Text] [Related]
6. ITPR3 gene haplotype is associated with cervical squamous cell carcinoma risk in Taiwanese women.
Yang YC; Chang TY; Chen TC; Lin WS; Chang SC; Lee YJ
Oncotarget; 2017 Feb; 8(6):10085-10090. PubMed ID: 28036301
[TBL] [Abstract][Full Text] [Related]
7. Genetic susceptibility to cervical neoplasia.
Brown MA; Leo PJ
Papillomavirus Res; 2019 Jun; 7():132-134. PubMed ID: 30954690
[TBL] [Abstract][Full Text] [Related]
8. Polymorphic variants INSIG2 rs6726538, HLA-DRB1 rs9272143, and GCNT1P5 rs7780883 contribute to the susceptibility of cervical cancer in the Bangladeshi women.
Hasan ME; Matin M; Haque ME; Aziz MA; Millat MS; Uddin MS; Moghal MMR; Islam MS
Cancer Med; 2021 Mar; 10(5):1829-1838. PubMed ID: 33586351
[TBL] [Abstract][Full Text] [Related]
9. Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri.
Beskow AH; Gyllensten UB
Int J Cancer; 2002 Oct; 101(6):526-31. PubMed ID: 12237892
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
[TBL] [Abstract][Full Text] [Related]
11. HLA-A, HLA-B, HLA-DRB1 polymorphisms and risk of cervical squamous epithelial cell carcinoma: a population study in China.
Xiao X; Liu L; Li WJ; Liu J; Chen DJ
Asian Pac J Cancer Prev; 2013; 14(7):4427-33. PubMed ID: 23992015
[TBL] [Abstract][Full Text] [Related]
12. Decreased frequency of HLA-DRB1 13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix.
Sastre-Garau X; Loste MN; Vincent-Salomon A; Favre M; Mouret E; de la Rochefordiere A; Durand JC; Tartour E; Lepage V; Charron D
Int J Cancer; 1996 Jun; 69(3):159-64. PubMed ID: 8682580
[TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women.
Maciag PC; Schlecht NF; Souza PS; Franco EL; Villa LL; Petzl-Erler ML
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1183-91. PubMed ID: 11097225
[TBL] [Abstract][Full Text] [Related]
14. Association of Parkinson disease with structural and regulatory variants in the HLA region.
Wissemann WT; Hill-Burns EM; Zabetian CP; Factor SA; Patsopoulos N; Hoglund B; Holcomb C; Donahue RJ; Thomson G; Erlich H; Payami H
Am J Hum Genet; 2013 Nov; 93(5):984-93. PubMed ID: 24183452
[TBL] [Abstract][Full Text] [Related]
15. Host and viral genetics and risk of cervical cancer: a review.
Hildesheim A; Wang SS
Virus Res; 2002 Nov; 89(2):229-40. PubMed ID: 12445662
[TBL] [Abstract][Full Text] [Related]
16. HLA class II susceptibility to cervical cancer among Tunisian women.
Ben Othmane Y; Ghazouani E; Mezlini A; Lagha A; Raïs M; Kochkar R; Zidi S; Afrit M; Mota-Vieira L; Yacoubi Loueslati B
Bull Cancer; 2012 Sep; 99(9):81-6. PubMed ID: 22863772
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation in cervical preinvasive and invasive disease: a genome-wide association study.
Bowden SJ; Bodinier B; Kalliala I; Zuber V; Vuckovic D; Doulgeraki T; Whitaker MD; Wielscher M; Cartwright R; Tsilidis KK; Bennett P; Jarvelin MR; Flanagan JM; Chadeau-Hyam M; Kyrgiou M;
Lancet Oncol; 2021 Apr; 22(4):548-557. PubMed ID: 33794208
[TBL] [Abstract][Full Text] [Related]
18. Significant association between IL10-1082/-819 and TNF-308 haplotypes and the susceptibility to cervical carcinogenesis in women infected by Human papillomavirus.
Chagas BS; Lima RCP; Paiva Júnior SSL; Silva RCO; Cordeiro MN; Silva Neto JDC; Batista MVA; Silva AJD; Gurgel APAD; Freitas AC
Cytokine; 2019 Jan; 113():99-104. PubMed ID: 29935877
[TBL] [Abstract][Full Text] [Related]
19. HLA-DRB1 alleles and cervical cancer: A meta-analysis of 36 case-control studies.
Kamiza AB; Kamiza S; Mathew CG
Cancer Epidemiol; 2020 Aug; 67():101748. PubMed ID: 32562888
[TBL] [Abstract][Full Text] [Related]
20. Protective association of HLA-DRB1*13:02, HLA-DRB1*04:06, and HLA-DQB1*06:04 alleles with cervical cancer in a Korean population.
Shim H; Park B; Shin HJ; Joo J; Yoon KA; Kim YM; Hayashi T; Tokunaga K; Kong SY; Kim JY
Hum Immunol; 2019 Feb; 80(2):107-111. PubMed ID: 30352277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
